This inventor holds 36 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Genomic Diagnostics. Top assignees: The Broad Institute, Inc., Massachusetts Institute of Technology, Harvard College. Active years: 2002-2025.
Company Filing History:
21 out of 480Â 
18 out of 8,568Â 
14 out of 3,069Â 
Years Active: 2002-2025
Areas of Expertise:
Title: Eric Lander: Co-founder of the Broad Institute and Pioneering Innovator
Introduction:
Eric Lander is a renowned innovator and scientist in the field of genomics. As a co-founder of the Broad Institute of MIT and Harvard, Lander has made significant contributions to the advancement of molecular biology and healthcare solutions. With a vast array of patents and extensive collaborations, Lander has cemented his position as a groundbreaking figure in the field of genomics.
Latest Patents:
Lander's latest patents highlight his visionary approach towards addressing pressing global health challenges. One notable patent is the CRISPR effector system based diagnostics for malaria detection. This patent introduces a highly sensitive CRISPR-based diagnostic tool capable of detecting both DNA and RNA, differentiating targets from non-targets with single base pair differentiation. The invention's freeze-dried format enables convenient distribution and point-of-care applications, making it an invaluable asset in healthcare scenarios such as viral detection and disease-associated DNA detection.
Another notable patent by Lander is the massively multiplexed RNA sequencing protocol. This invention revolutionizes the field of genomics by facilitating the parallel sequencing of target RNA from multiple sources while maintaining source identification. The method allows for efficient and accurate sequencing of dozens to thousands of samples simultaneously, opening up new possibilities for research and disease detection.
Career Highlights:
Apart from his co-founding role at the Broad Institute, Lander has also contributed significantly to other prestigious institutions. He has served as a key member of The Broad Institute, Inc., where he continues to inspire and mentor numerous researchers in the field. Additionally, Lander has made significant contributions during his involvement with the Massachusetts Institute of Technology (MIT), further solidifying his expertise and influence in genomics.
Collaborations:
Throughout his career, Lander has collaborated closely with notable scientists, further fueling innovation and progress in genomics. Two standout collaborators include Feng Zhang and Omar O Abudayyeh. Feng Zhang is renowned for his work in developing CRISPR-Cas technologies, while Omar O Abudayyeh has made significant contributions to the field of CRISPR-based diagnostics. These collaborations demonstrate Lander's dedication to fostering interdisciplinary partnerships and pushing the boundaries of genomics research.
Conclusion:
Eric Lander's contributions as a co-founder of the Broad Institute of MIT and Harvard have had a profound impact on the field of genomics. With his numerous patents and groundbreaking inventions, he has paved the way for advancements in molecular biology and healthcare. Lander's visionary leadership and collaborative nature continue to inspire researchers in their pursuit of innovative solutions to current and future challenges in genomics. His influence will undoubtedly shape the landscape of genomic research for years to come.